[Drug and Device Law] Res Ipsa Loquitur, or Maybe Not
We haven't written much about res ipsa loquitur on the blog, and today's case doesn't really qualify as a drug or device case per se, but it's an interesting opinion and we thought it was worth sharing. The case is Hubbard v. Mellion, No. 108461, 2013 Kan. App. LEXIS 45 (May 17, 2013), and it's an appellate decision reversing summary judgment in favor of a physician in a medical negligence case, on the basis of the appellate court's finding that the lower court should have applied the doctrine of res ipsa loquitur. The case arose when plaintiff Hubbard underwent spinal surgery (involving various –otomies and –ectomies) to repair a herniated lumbar disc. During the procedure, the surgeon used a device known as a pituitary rongeur, which is a forceps-type instrument that's used to remove part of the disc. Unfortunately, during Ms. Hubbard's surgery, the tip broke off of one arm of the rongeur, and became lodged in her disc space. Hubbard, 2013 Kan. App. LEXIS at * 6. The surgeon tried to retrieve the tip but was unable to. Id. Ms. Hubbard claimed that she experienced continual pain as a result of having the fragment in her spine, and eventually underwent another surgery to remove it. Id. She later filed a negligence action in which she named the surgeon and the hospital, as well as the manufacturer of the rongeur, alleging that the latter was negligent for supplying a device that was in a dangerous and defective condition. However, as we've seen plaintiffs do in other medical device cases, plaintiff later decided to pursue the surgeon alone, and backed away from her defect theory. Really far away. Did a 180, in fact. Not only did plaintiff dismiss the manufacturer, her expert metallurgist authored a report in which he "ruled out the possibility that the rongeur failed due to a manufacturer's defect, ruled out the possibility that the rongeur failed because it had been improperly maintained, and ruled out the possibility that the rongeur had failed due to normal wear and tear." Id. at *11. The plaintiff's expert's sole causation opinion was that the rongeur tip had broken off due to user error – specifically, because the surgeon had applied too much force when using the instrument. Id. at *12.
The surgeon moved for summary judgment on the basis that plaintiff's experts – a metallurgist, a neurosurgeon, and a quality management team leader from the rongeur manufacturer (id. at *11-12) – were not qualified to opine on the standard of care for a surgeon performing this type of procedure. Id. at * 14-15. The trial court agreed, and held that although these experts established that operator error had caused the rongeur to break, plaintiff had not shown that this error was outside the established standard of care. Id. at *15. On appeal, plaintiff argued that she was not required to present expert testimony on the standard of care because there were two exceptions to the requirement that applied in this case: the "common knowledge" exception and/or the doctrine of res ipsa loquitur. Id. at *20.
he played no role in the design or manufacture of the rongeur, he was not the manufacturer of the rongeur, he did not own the rongeur, he played no role in the maintenance of the rongeur, he was not the individual charged with the responsibility to pull the rongeur from service at the end of its useful life, and the rongeur had been used by an unknown number of physicians prior to its failure in February 2008.
Id.at *26. The appellate court was, in its own words, not persuaded. The court first noted that the plaintiff's expert metallurgist had ruled out a manufacturing defect, improper maintenance, and normal wear as causes of the failure. Id. It also found that "exclusive control" had to be a flexible concept, allowing for a finding that control exists even where the defendant only shared in the control of the instrument. Id. at *27. The court reached back to Prosser and Keeton on this point – well, on the concept of "control" anyway, not "exclusive control," which makes us a bit uncomfortable. And we wonder how flexible this concept is meant to be – i.e., if the only defendant in the case had been the manufacturer of the rongeur, would this court have allowed the concept to stretch far enough to find the manufacturer in "exclusive control" of the instrument at the time of injury? And we wonder further: in cases where both the manufacturer and surgeon are named, where does res ipsa come in? Can the plaintiff get the inference against the manufacturer if the manufacturer chooses not to point the finger at the surgeon? While it's true that the thing sometimes speaks for itself, sometimes it's what's not said that is troubling.
--
Posted By Melissa Wojtylak to Drug and Device Law at 5/31/2013 11:49:00 AM --
--
You received this message because you are subscribed to the Google Groups "Drug and Device Law" group.
To post to this group, send email to drug-and-device-law@googlegroups.com
To unsubscribe from this group, send email to drug-and-device-law-unsubscribe@googlegroups.com
For more options, visit this group at http://groups.google.com/group/drug-and-device-law?hl=en
---
You received this message because you are subscribed to the Google Groups "Drug and Device Law" group.
To unsubscribe from this group and stop receiving emails from it, send an email to drug-and-device-law+unsubscribe@googlegroups.com.
For more options, visit https://groups.google.com/groups/opt_out.
No comments:
Post a Comment